Dissecting the clinical heterogeneity of early-onset Alzheimer's disease

DW Sirkis, LW Bonham, TP Johnson, R La Joie… - Molecular …, 2022 - nature.com
Early-onset Alzheimer's disease (EOAD) is a rare but particularly devastating form of AD.
Though notable for its high degree of clinical heterogeneity, EOAD is defined by the same …

New insights into the role of ferritin in iron homeostasis and neurodegenerative diseases

N Zhang, X Yu, J Xie, H Xu - Molecular neurobiology, 2021 - Springer
Growing evidence has indicated that iron deposition is one of the key factors leading to
neuronal death in the neurodegenerative diseases. Ferritin is a hollow iron storage protein …

Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease

E Guzmán-Vélez, I Diez… - Proceedings of the …, 2022 - National Acad Sciences
The human brain is composed of functional networks that have a modular topology, where
brain regions are organized into communities that form internally dense (segregated) and …

Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease …

ECB Johnson, K Ho, GQ Yu, M Das… - Molecular …, 2020 - Springer
Background Alzheimer's disease (AD) is the most frequent and costly neurodegenerative
disorder. Although diverse lines of evidence suggest that the amyloid precursor protein …

Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer's disease

Y Gloria, K Ceyzériat, S Tsartsalis, P Millet… - Scientific reports, 2021 - nature.com
Alzheimer's disease (AD) is characterized by amyloid (Aβ) protein aggregation and
neurofibrillary tangles accumulation, accompanied by neuroinflammation. With all the …

Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker study

JS Sanchez, BJ Hanseeuw, F Lopera… - Alzheimer's research & …, 2021 - Springer
Background Neuroimaging studies of autosomal dominant Alzheimer's disease (ADAD)
enable characterization of the trajectories of cerebral amyloid-β (Aβ) and tau accumulation …

Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease

JJ Llibre-Guerra, L Iaccarino, D Coble… - Brain …, 2023 - academic.oup.com
Approximately 5% of Alzheimer's disease cases have an early age at onset (< 65 years),
with 5–10% of these cases attributed to dominantly inherited mutations and the remainder …

Associations between subregional thalamic volume and brain pathology in autosomal dominant Alzheimer's disease

E Pardilla-Delgado, H Torrico-Teave… - Brain …, 2021 - academic.oup.com
Histopathological reports suggest that subregions of the thalamus, which regulates multiple
physiological and cognitive processes, are not uniformly affected by Alzheimer's disease …

Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors

PNH Trinh, DJW Chong, K Leach, SJ Hill… - Journal of Medicinal …, 2021 - ACS Publications
Adenosine receptors are attractive therapeutic targets for multiple conditions, including
ischemia-reperfusion injury and neuropathic pain. Adenosine receptor drug discovery efforts …

Morphine and HIV-1 Tat interact to cause region-specific hyperphosphorylation of tau in transgenic mice

M Ohene-Nyako, SR Nass, YK Hahn, PE Knapp… - Neuroscience …, 2021 - Elsevier
Opiate abuse is prevalent among HIV-infected individuals and may exacerbate HIV-
associated age-related neurocognitive disorders. However, the extent to which HIV and …